National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
75.00
-0.54 (-0.71%)
Apr 24, 2025, 11:06 AM EDT - Market open

National Health Investors Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for National Health Investors stock have an average target of 82.2, with a low estimate of 69 and a high estimate of 92. The average target predicts an increase of 9.60% from the current stock price of 75.00.

Analyst Consensus: Buy
Target Low Average Median High
Price $69 $82.2 $86 $92
Change -8.00% +9.60% +14.67% +22.67%
* Price targets were last updated on Mar 19, 2025.

Analyst Ratings

The average analyst rating for National Health Investors stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 222211
Buy 444422
Hold 422222
Sell 000000
Strong Sell 000000
Total 1088855

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Truist Securities
Truist Securities
Hold
Maintains
$70$76
Hold Maintains $70$76 +1.33% Mar 19, 2025
Wedbush
Wedbush
Buy
Reiterates
$88
Buy Reiterates $88 +17.33% Mar 17, 2025
Truist Securities
Truist Securities
Hold
Maintains
$78$72
Hold Maintains $78$72 -4.00% Dec 23, 2024
Wells Fargo
Wells Fargo
Hold
Initiates
$81$86
Hold Initiates $81$86 +14.67% Oct 1, 2024
B of A Securities
B of A Securities
Strong Buy
Initiates
$92
Strong Buy Initiates $92 +22.67% Sep 24, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
356.12M
from 335.58M
Increased by 6.12%
Revenue Next Year
400.38M
from 356.12M
Increased by 12.43%
EPS This Year
3.15
from 3.13
Increased by 0.61%
EPS Next Year
3.32
from 3.15
Increased by 5.52%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
329.69M297.17M278.76M320.39M335.58M356.12M400.38M437.64M
Revenue Growth
3.65%-9.86%-6.19%14.93%4.74%6.12%12.43%9.31%
EPS
4.142.441.483.133.133.153.323.36
EPS Growth
12.81%-41.06%-39.34%111.16%0.16%0.61%5.52%1.22%
Forward PE
-----23.8222.5722.30
No. Analysts
-----663
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 416.8M 512.5M 601.7M
Avg 356.1M 400.4M 437.6M
Low 325.3M 337.6M 342.9M

Revenue Growth

Revenue Growth 20252026202720282029
High
24.2%
43.9%
50.3%
Avg
6.1%
12.4%
9.3%
Low
-3.1%
-5.2%
-14.4%

EPS Forecast

EPS 202520262027
High 3.42 3.61 3.50
Avg 3.15 3.32 3.36
Low 2.95 3.12 3.26

EPS Growth

EPS Growth 202520262027
High
9.4%
14.7%
5.2%
Avg
0.6%
5.5%
1.2%
Low
-5.8%
-1.0%
-1.8%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.